324 filings
Page 2 of 17
8-K
4pku4v8 av
12 Feb 24
Other Events
4:18pm
D
gleqizdpocxvd41h
12 Feb 24
$49.99 mm in equity / options, sold $49.99 mm, 11 investors
12:08pm
8-K
eosxm9
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
S-8
la0hma9azgfkwkq8
21 Dec 23
Registration of securities for employees
7:07pm
8-K
zdi7nadxjg
5 Dec 23
Entry into a Material Definitive Agreement
5:04pm
8-K
lomnvjjvrx
6 Nov 23
Amendments to Articles of Incorporation or Bylaws
8:21pm
DEF 14C
uzsrdy6sd5xvega7xi6
16 Oct 23
Information statement
6:16pm
8-K
xhjb73y5s miif4jk
3 Oct 23
Departure of Directors or Certain Officers
4:34pm
PRE 14C
rtxrc3kr 5g2p
3 Oct 23
Preliminary information
4:12pm
8-K
jrkm 64it2sf
7 Sep 23
Skye Bioscience Reverse Stock Split to be Effective on September 8th
1:15pm
8-K/A
smbchu
1 Sep 23
Departure of Directors or Certain Officers
12:00am
D
jgoj1a it
29 Aug 23
$62.25 mm in equity / debt / options / securities to be acquired, sold $62.25 mm, 12 investors
4:56pm
8-K
rprl6qppeo31dsd
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K/A
2kh5nnk909 9f
27 Mar 23
Departure of Directors or Certain Officers
4:09pm
8-K
33agx tto
23 Feb 23
Entry into a Material Definitive Agreement
5:18pm
8-K
fsg 7nn86r8
16 Feb 23
Skye Bioscience Appoints Deborah Charych, PhD to Board of Directors
5:16pm